Show
Sort by
-
Melanoma-associated leukoderma and vitiligo cannot be differentiated based on blinded assessment by experts in the field
-
Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants
-
In vivo vitiligo induction and therapy model: double-blind, randomized clinical trial
-
Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo
-
Melanocyte-specific immune response in a patient with multiple regressing nevi and a history of melanoma
-
First histopathological and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo nevi